Yao‐Feng Li

562 total citations
45 papers, 370 citations indexed

About

Yao‐Feng Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yao‐Feng Li has authored 45 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Yao‐Feng Li's work include Glioma Diagnosis and Treatment (8 papers), Ferroptosis and cancer prognosis (5 papers) and RNA Research and Splicing (5 papers). Yao‐Feng Li is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Ferroptosis and cancer prognosis (5 papers) and RNA Research and Splicing (5 papers). Yao‐Feng Li collaborates with scholars based in Taiwan, China and United States. Yao‐Feng Li's co-authors include Dueng‐Yuan Hueng, Li‐Chun Huang, Shih‐Ming Huang, Wen‐Chiuan Tsai, Chia‐Kuang Tsai, Chung-Hsing Chou, Chin Lin, Peizhong Liu, Jing-Ming Guo and Hung‐Yi Chiou and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Scientific Reports.

In The Last Decade

Yao‐Feng Li

41 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yao‐Feng Li Taiwan 12 153 66 65 56 53 45 370
Zijun Huo China 11 177 1.2× 65 1.0× 68 1.0× 27 0.5× 33 0.6× 26 350
Wei An China 14 304 2.0× 56 0.8× 92 1.4× 59 1.1× 59 1.1× 38 628
Myung‐Giun Noh South Korea 11 145 0.9× 61 0.9× 61 0.9× 25 0.4× 23 0.4× 35 297
Jared S. Rosenblum United States 11 151 1.0× 118 1.8× 24 0.4× 79 1.4× 44 0.8× 38 416
Chris Van Dijk Netherlands 13 228 1.5× 68 1.0× 52 0.8× 89 1.6× 27 0.5× 22 565
Grzegorz T. Gurda United States 14 198 1.3× 76 1.2× 116 1.8× 118 2.1× 25 0.5× 36 536
Omanma Adighibe United Kingdom 8 228 1.5× 120 1.8× 61 0.9× 46 0.8× 35 0.7× 10 354
Shih-Hwa Chiou Taiwan 12 274 1.8× 59 0.9× 49 0.8× 25 0.4× 37 0.7× 18 450
Meiyan Feng China 12 219 1.4× 64 1.0× 29 0.4× 38 0.7× 36 0.7× 22 469
Maurizio Polano Italy 14 213 1.4× 81 1.2× 202 3.1× 77 1.4× 67 1.3× 31 599

Countries citing papers authored by Yao‐Feng Li

Since Specialization
Citations

This map shows the geographic impact of Yao‐Feng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao‐Feng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao‐Feng Li more than expected).

Fields of papers citing papers by Yao‐Feng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao‐Feng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao‐Feng Li. The network helps show where Yao‐Feng Li may publish in the future.

Co-authorship network of co-authors of Yao‐Feng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yao‐Feng Li. A scholar is included among the top collaborators of Yao‐Feng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao‐Feng Li. Yao‐Feng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Chang, Yung‐Lung, Chung-Hsing Chou, Yao‐Feng Li, et al.. (2023). Antiproliferative and apoptotic effects of telmisartan in human glioma cells. Cancer Cell International. 23(1). 111–111. 11 indexed citations
4.
Liu, Tung, et al.. (2023). Elucidating the Role of SLC4A7 in Glioma Prognosis. SHILAP Revista de lepidopterología. 43(5). 202–211. 2 indexed citations
6.
Chen, Hsuan‐Yu, et al.. (2022). Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin. International Journal of Molecular Sciences. 23(15). 8171–8171. 25 indexed citations
7.
Kuo, Feng-Chih, Yuting Wang, Yao‐Feng Li, et al.. (2022). LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1. Cancer Cell International. 22(1). 396–396. 7 indexed citations
8.
Li, Yao‐Feng, Simon Picker, T. J. Stone, et al.. (2021). Identifying cellular signalling molecules in developmental disorders of the brain: Evidence from focal cortical dysplasia and tuberous sclerosis. Neuropathology and Applied Neurobiology. 47(6). 781–795. 11 indexed citations
9.
Li, Yao‐Feng, Chung-Hsing Chou, Li‐Chun Huang, et al.. (2021). GRPEL2 Knockdown Exerts Redox Regulation in Glioblastoma. International Journal of Molecular Sciences. 22(23). 12705–12705. 7 indexed citations
10.
Gao, Hong‐Wei, Chia-Ming Chang, Kai-Hsi Lu, et al.. (2021). Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis. Biomedicines. 9(8). 866–866. 3 indexed citations
12.
Chang, Tsu‐Chung, et al.. (2021). 4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation. Biomedicine & Pharmacotherapy. 138. 111504–111504. 23 indexed citations
13.
Chang, Chia-Ming, Yao‐Feng Li, Hsin‐Chung Lin, et al.. (2021). Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics. International Journal of Molecular Sciences. 22(8). 4105–4105. 1 indexed citations
14.
Li, Yao‐Feng, Wen‐Chiuan Tsai, Chung-Hsing Chou, et al.. (2020). CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines. International Journal of Molecular Sciences. 22(1). 197–197. 17 indexed citations
15.
Miao, Shuo, Sumei Wang, Xue Cheng, et al.. (2017). Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor. Cancer Cell International. 17(1). 119–119. 23 indexed citations
16.
Li, Yao‐Feng, et al.. (2014). Epstein-Barr Virus Infection Mimicking Drug-Induced Hepatitis in a Critically ill Patient During Antituberculosis Therapy. Hepatitis Monthly. 14(9). e18865–e18865. 1 indexed citations
17.
Yeo, Yee Hui, et al.. (2014). Hepatobiliary cystadenocarcinoma without mesenchymal stroma in a female patient: a case report. BMC Gastroenterology. 14(1). 109–109.
18.
Hsieh, Cheng-Ta, et al.. (2011). Textiloma as a complication of transsphenoidal surgery.. PubMed. 16(4). 369–71. 4 indexed citations
20.
Li, Yao‐Feng, Tai‐Lung Cha, Jong‐Shiaw Jin, & Cheng‐Ping Yu. (2010). Chromophobe Renal Cell Carcinoma with Osteosarcoma Differentiation: Case Report and Literature Review. Urologia Internationalis. 85(4). 470–474. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026